Combination Effect of Anti-Fas Antibody and Chemotherapeutic Drugs in Ovarian Cancer Cells in vitro

Oncology (Switzerland)

Volumn 54, Issue 1, 1997, Pages 48-54

  Wakahara, Yasunori ^a   Nawa, Akihiro ^a   Okamoto, Tomomitsu ^a   Hayakawa, Akemi ^b   Kikkawa, Fumitaka ^a   Suganuma, Nobuhiko ^a   Wakahara, Fumiyo ^a   Tomoda, Yutaka ^a  

^a Department of Obstetrics and Gynecology ^*  (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Drug resistance; Etoposide; Fas; SN 38

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

ANTIGENS, CD95; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOTHERAPY; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031060430     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227661     Document Type: Article

References (29)

1. Yonchara S, lshi A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor, J Exp Med 1989:169: 1747-1756.
2. Itoh N, Yonchara S, ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell 1991:66:233-243.
3. Trauth BC, Klas C, Peters AMJ, Matzku S, Mollcr P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis, Science 1989: 245:301-305.
4. Oehm A, Bchrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamilv, Sequence identity with the Fas antigen, J Biol Chem 1992:267:10709-10715.
5. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis, J Exp Med 1994:179:873-879.
6. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L: Mitotic block induccd in Hela cells by low concentrât ions of paclitaxel (taxol) results in abnormal mitotic exit and apoptotic cell death, Cancer Res 1996:56:816-825.
7. Soldatenkov VA, Prasad S, Notario V, Drit-schilo A: Radiation-induced apoptosis of Ewing’s sarcoma cells: DNA fragmentation and proteolysis of poly (ADP-ribose) polymerase, CancerRes 1995;55:4240-4242.
8. Leithauser F, Dhein J, Mechtcrsheimcr G, Koretz K, Brudcrlcin S, Henne C, Schmidt A, Debatin KM, Krammer PH, Moller P: Constitutive and induced expression of APO-1, a new number of the nerve growth factor/tumor necrosis factor receptor superfamilv, in normal and neoplastic cells, Lab Invest 1993:69:415-429.
9. Kikuchi Y, Kizawa I, Oomori K, Miyauchi M, Kita T, Sugita M, Tcnjin Y, Kato K: Establishment of a human ovarian cancer ccll line capable of forming ascites in nude mice and effects of tranexamic acid on ccll proliferation and ascites formation, Cancer Res 1987:47:592-596.
10. Chou TC, Talalay P: Quantitative analysis dose-effect relationship: The combined effect of multiple drugs or enzyme inhibitors, Adv Enzyme Regul 1984:22:27-55.
11. Schmid DS, Tite JP, Ruddle NH: DNA fragmentation: Manifestation of target cell destruction mediated by cytotoxic T-cell lines, lym-photoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant, Proc Natl Acad Sei USA 1986:83:1881-1885.
12. Uckcr DS: Cytotoxic T lymphocytes and glucocorticoids activate an endogenous suicide process in target cells, Nature 1987:327:62-64.
13. Owcn-Schaub LB, Yonehara S, Crump W, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement, Ccll Immunol 1992;140:197-205.
14. Miyawaki T, Uehara T, Nibu R, Tsuji T, Ya-chie A, Yonchara S, Taniguchi N: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood, J Immunol 1992;149:3753-3758.
15. Debatin KM, Goldman CK, Waldmann TA, Krammer PH: APO-1-induccd apoptosis of leukemia cells from patients with adult T-cell leukemia, Blood 1993:81:2972-2977.
16. Mapara MY, Bargou R, Zugck C, Dohner H, Ustaoglu F, Jonker RR, Krammer PH, Dorken B: APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl-2 oncogene expression, Eur J Immunol 1993;23:702-708.
17. Wong GH, Gocddel DV: Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways, J Immunol 1994;152:1751-1755.
18. Owcn-Schaub LB, Radinsky R, Kruzcl E, Berry K, Yonchara S: Anti-Fas on nonhematopoietic tumors: Levels of Fas/APO-l and bcl-2 are not predictive of biological responsiveness, Cancer Res 1994:54:1580-1586.
19. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death, J Immunol 1993:151:621-627.
20. McGahon AJ, Nishioka WK, Martin SJ, Mah-boufci A, Cotter TG, Green DR: Regulation of the Fas apoptotic cell death pathway by Abl, J Biol Chem 1995;270:22625-22631.
21. Enari M, Hug H, Nagata S: Involvement of an ICE-1 ike proteasc in Fas-mediated apoptosis, Nature 1995;375:78-81.
22. Sato T, Irie S, Kitada S, Reed JC: FAP-I: A protein tyrosine phosphatase that associates with Fas, Science 1995:268:411-415.
23. Cifone MG, DcMaria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, Testi R: Apoptotic signaling through CD95 (Fas/Apo-1) activates an acid sphingomyelinase, J Exp Med 1994:177:1547-1552.
24. Morimoto H, Yonehara S, Bonavida B: Overcoming tumor necrosis factor and drug resistance of human tumor ccll lines by combination treatment with anti-Fas antibody and drugs or toxins, Cancer Res 1993:53:2591-2596.
25. Alexander RB, Nelson WG, Coffey DS: Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II, Cancer Res 1987:47:2403-2406.
26. Mutch DG, Powell CB, Kao MS, Collins JL: In vitro analysis of the anti-cancer potential of tumor necrosis factor in combination with cis-platinum, Gynecol Oncol 1989;34:328-333.
27. Safnt JT, Bonavida B: Sensitivity of resistant human tumor cell lines to TNF and Adriamy-cin used in combination: Role of TNF-mRNA induction in overcoming resistance, Cancer Res 1992;52:6630-6637.
28. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S: Lethal effect of the anti-Fas antibody in mice, Nature 1993:364:806-809.
29. Rensing-Ehl A, Frei K, Flury R, Matiba B, Mariani SM, Weller M, Acbischer P, Krammer PH, Fontana A: Local Fas/APO-l (CD95) li-gand-mediated tumor cell killing in vivo, Eur J Immunol 1995;25:2253-2258.